Business Wire

Stelo by Dexcom First Glucose Biosensor to be Cleared by FDA as Over-the-Counter

SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today that the FDA has cleared Stelo by Dexcom ...
Business Wire

Stelo by Dexcom, the First Over-the-Counter Glucose Biosensor in the U.S., Is Now Available

SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today that Stelo, the first over-the-counter ...
Yahoo Finance

DexCom's (DXCM) Stelo Glucose Biosensor Receives FDA Approval

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
CNET

FDA Clears First Over-the-Counter Continuous Glucose Monitor: What to Know About Biosensors

The US Food and Drug Administration on Tuesday cleared the first over-the-counter continuous glucose monitoring system (CGM) in the US — the Dexcom Stelo Glucose Biosensor System — expanding glucose ...
Monthly Prescribing Reference

Stelo OTC Wearable Glucose Biosensor Now Available

Credit: Dexcom. Stelo is an integrated CGM that continuously measures, records, analyzes, and displays glucose values in individuals 18 years of age and older who are not on insulin. Dexcom’s Stelo ...
CNBC

Dexcom's over-the-counter glucose monitor now offers users an AI summary of how sleep, meals and more impact sugar levels

Dexcom on Tuesday announced its first generative AI feature for its Stelo biosensor that gives users a personalized weekly report about their glucose. The company has been building a generative AI ...
Hosted on MSN

Trying an OTC CGM for diabetes? Compare Stelo, Lingo and Levels before buying one

Over-the-counter continuous glucose monitors have moved from a diabetes-only tool into the broader metabolic health conversation, and shoppers now face a real decision. Here is an OTC CGM comparison ...
Monthly Prescribing Reference

Dexcom Stelo Biosensor Cleared as First OTC Continuous Glucose Monitor

Credit: Dexcom. The Dexcom Stelo Glucose Biosensor System is an integral CGM intended for individuals 18 years of age and older with or without diabetes who are not on insulin. The Food and Drug ...
Nasdaq

Stelo by Dexcom First Glucose Biosensor to be Cleared by FDA as Over-the-Counter

Stelo will be the first glucose biosensor in the US cleared for use without a prescription Indicated for use for people 18 years and older who are not using insulin therapy A small, wearable sensor ...
Nasdaq

DexCom's (DXCM) Stelo Glucose Biosensor Receives FDA Approval

DexCom Inc. DXCM recently announced the FDA clearance of its Stelo glucose biosensor, available over-the-counter to consumers without a prescription. The company’s latest Continuous Glucose Monitoring ...
BetaNews

DexCom launches Stelo, first over-the-counter glucose biosensor in U.S., available without prescription

DexCom, a maker of real-time continuous glucose monitoring devices, announced today the availability of Stelo, the first over-the-counter glucose biosensor in the U.S., now purchasable without a ...